“Dear Professor Kenyon, I am eleven years old, and, ever since I was six, have developed an acute interest in the study of the extension of human life. I think the research you are doing is amazing. I was wondering if I could meet you to ask some questions about a career in biology?”

SAN FRANCISCO — So began an email from Laura Deming of Auckland, New Zealand, to Cynthia Kenyon, a professor at the University of California, San Francisco. Kenyon had revolutionized aging research with her discovery that a single-gene mutation could double the lifespan of a tiny roundworm called C. elegans. Her finding triggered a hunt for therapies to extend the human lifespan that today is one of the hottest areas in medical research.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy